TAGCyx Biotechnologies

Sabina, Campania, Italy, 153-0041

Company profile

TAGCyx Biotechnologies company profile

TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.

Business identity

Website: http://tagcyx.com/en/
Contact email: [email protected]
Phone number: +81-3-6407-1672
Operating status: Active
Company type: For Profit
Employee range: 11-50 employees
Revenue range: $0-$1M
Founded: 2007-03-22

LinkedIn Facebook

Headquarters

Headquarters: Sabina, Campania, Italy
Postal code: 153-0041
Country code: IT
Continent: Europe

Capital profile

Funding and company signals

Funding rounds: 4
Total equity funding: $13.2M
Last funding: Series Unknown / $1.9M / 2021-07-07
Last equity funding: Series Unknown / $1.9M
Investors: 7
Lead investors: 1
Articles: 8

Categories and groups

Biotechnology Environmental Consulting Nuclear Biotechnology Professional Services Science and Engineering

Founders and investors

Lead investors

UTEC - The University of Tokyo Edge Capital Partners

Investors

Mizuho CapitalNissay CapitalSMBC Venture CapitalUTEC - The University of Tokyo Edge Capital PartnersUTokyo Innovation Platform

TAGCyx Biotechnologies